All News

Novavax’s recombinant quadrivalent flu vaccine candidate (NanoFlu) is being evaluated in an ongoing phase 3 clinical study for use in older adults.

Here are 4 pharmacy-related New Year’s resolutions that can help enhance your pharmacy services.

Shingles vaccination recommended by CDC and ADCES.

The opioid crisis continues to be one of the worst public health crises that the United States has ever seen.

Progress has been made, but there’s still a long road ahead.

Eli Lilly added additional affordability options for patients with diabetes who use certain insulin products.

Antipsychotics were not associated with an increased risk of morbidity and mortality in patients with schizophrenia in a new study. 

Optimism is strong around the pharmacy industry as we head into a new decade, and many believe that 2020 is going to be a pivotal year for the industry.

Patients with diabetes now have access to more technology than ever before to help them manage the chronic disease, but the devices can be complicated for patients to use.

Here are the top drugs expected to be approved this year.

NACDS says DIR fees, other policies need to change.

Viaskin Peanut (DBV Technologies) achieved durable, long-term clinical benefit in peanut-allergic children.

Individuals with a history of heart disease may be at an increased risk of developing kidney failure.

In a new lawsuit, CVS, Walgreen, Rite Aid, and other major pharmacy chains said that they are not to blame in federal opioid litigation

Overall cancer death rates declined by 29% over a 26-year time period, with the largest single-year drop on record reported from 2016 to 2017.

Prediabetes can increase the risk the risk of developing type 2 diabetes.

Are the benefits of lowering systolic blood pressure to less than 130 mm Hg the same for those aged 80 years and older as they are for younger patients?

What are some of the factors affecting whether a brand-name drug has generic competition?

AstraZeneca’s supplemental New Drug Application for dapagliflozin (Farxiga) has been granted Priority Review by the FDA.

Insulin aspart injection (Fiasp, Novo Nordisk) has been approved for use as a new mealtime insulin option for children with diabetes.

The critical role of distributors amid natural disasters, and strategies to protect and maintain the pharma supply chain

The New Drug Application is seeking approval for ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine for the treatment of HIV in adults.

Due to ongoing insulin affordability challenges, Novo Nordisk is offering new cost assistance options for patients with diabetes.

A new study examined diabetes as an independent predictor of heart failure. 

A 2016 California policy that eliminated non-medical vaccination exemptions for schoolchildren was linked to an increase in vaccine coverage.

Pharmacies can play an important role in raising awareness about efficient medication disposal methods.

Olaparib (Lynparza, Merck and AstraZeneca) is approved for the maintenance treatment of adult patients with germline BRCA-mutated metastatic pancreatic cancer.